U.S. Software Stock News

NasdaqGS:FFIN
NasdaqGS:FFINBanks

Is First Financial Bankshares (FFIN) Price Justified After Recent Rebound And Sector Concerns

If you are wondering whether First Financial Bankshares is reasonably priced or you might be overpaying at US$33.45, you are asking the right question before making any decisions. The share price has moved 1.1% over the last week, 5.1% over the past month, and 11.4% year to date, while the 1 year return sits at an 8.2% decline and the 3 and 5 year returns are 0.5% and 18.0% declines respectively. Recent coverage has focused on broad sector trends and regional bank conditions, which helps...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Is Innodata (INOD) Pricing AI Hopes Too High After Recent Share Price Swings

This article is designed to help you assess whether Innodata's share price aligns with its underlying worth, or if sentiment has run ahead of fundamentals. Innodata last closed at US$47.58, with a 4.3% return over the past week, an 18.9% decline over the past month, a 10.2% decline year to date, a 9.6% decline over 1 year and a very large 3 year and 5 year return that is more than 7x. Recent headlines around Innodata have focused on its role in data engineering and AI related services,...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics (ADMA) Margin Compression Challenges Bullish Growth Narratives Heading Into Earnings

ADMA Biologics (ADMA) has capped FY 2025 with fourth quarter revenue of US$139.2 million and basic EPS of US$0.21, while trailing twelve month revenue sits at US$510.2 million and EPS at US$0.62. The company has seen quarterly revenue move from US$117.5 million in Q4 2024 to US$139.2 million in Q4 2025, with basic EPS shifting from US$0.47 to US$0.21 over the same period. This sets up a results season where growth expectations and margin quality are front of mind for investors. See our full...
NYSE:HEI
NYSE:HEIAerospace & Defense

HEICO (HEI) Margin Expansion Reinforces Bullish Earnings Narrative Despite Premium P/E

HEICO (HEI) opened fiscal 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$1.36, supported by trailing 12 month net income of US$712.6 million and EPS of US$5.12, alongside 25.6% year over year earnings growth and a 20.1% earnings CAGR over five years. The company has seen revenue move from US$3.9 billion to US$4.6 billion and trailing 12 month net income rise from US$514.1 million to US$712.6 million, with earnings growth of 25.6% over the last year and forecasts calling for about...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix (NTNX) Profitability Run With US$103 Million Q2 Net Income Tests Bearish Narratives

Nutanix (NTNX) just posted Q2 2026 results with revenue of US$722.8 million and basic EPS of US$0.38, alongside net income of US$103.0 million, while the trailing twelve months show revenue of US$2.7 billion and basic EPS of US$0.99 on net income of US$267.1 million. Over recent quarters the company has seen revenue move from US$590.9 million in Q1 2025 to US$670.6 million in Q1 2026 and US$722.8 million in Q2 2026. Basic EPS has shifted from US$0.11 to US$0.23 and then US$0.38, which may...
NYSE:ASIC
NYSE:ASICInsurance

Ategrity Buyback Spotlights Capital Allocation And Earnings Per Share Focus

Ategrity Specialty Insurance Company Holdings (NYSE:ASIC) has authorized a new $50 million share repurchase program. The buyback plan allows the company to repurchase its common stock, subject to market conditions and other factors. This announcement adds a new capital deployment option alongside any existing uses of cash such as underwriting operations and potential growth initiatives. Ategrity Specialty Insurance Company Holdings focuses on specialty insurance, a segment where...
NasdaqGS:FIGR
NasdaqGS:FIGRConsumer Finance

Is Figure Technology Solutions (FIGR) Pricing Too High After Recent Share Price Swings?

If you are wondering whether Figure Technology Solutions at around US$34.04 is cheap, expensive, or somewhere in between, you are in the right place to size up what the current share price might actually reflect. The stock has been volatile recently, with a 3.4% gain over the last 7 days, a 45.8% decline over the last 30 days, and a 22.2% decline year to date, which can change how investors think about both upside potential and risk. Recent coverage of Figure Technology Solutions has focused...
NYSE:PRMB
NYSE:PRMBBeverage

Primo Brands Solar Move Links Sustainability Efforts With Valuation Debate

Primo Brands (NYSE:PRMB) has launched a large scale onsite solar project at its Poland Spring facility in Hollis, Maine. The project is being developed in partnership with Onyx Renewables and PowerFlex. The solar installation is designed to support facility operations, cut carbon emissions and provide long term energy cost visibility. For you as an investor, this move gives a concrete example of how Primo Brands is tying its bottled water and beverage operations to renewable power at a...
NYSE:FLO
NYSE:FLOFood

Flowers Foods Board Changes Put Governance And Earnings Story In Focus

Flowers Foods (NYSE:FLO) announced planned retirements of longtime board member George E. Deese and director Edward J. Casey, Jr. The company expects both directors to step down at the 2026 annual meeting. At the same time, Flowers Foods plans to reduce the size of its board from 11 to 9 members. The changes are intended to streamline the company’s governance structure and board oversight. Flowers Foods, a major producer of packaged bakery foods in the US, operates in a sector where brand...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

DiamondRock Hospitality Board Shift Tests Profitability And Growth Story

DiamondRock Hospitality (NasdaqGS:DRH) has announced the retirement of founding Chairman and inaugural CEO William W. McCarten after more than 20 years with the company. Bruce D. Wardinski has been appointed as the new non executive Chairman, marking a shift in board leadership. The company is also reducing the size of its board, signaling a change in its governance structure. For shareholders watching DiamondRock Hospitality at a share price of $10.33, this leadership handover comes after...
NYSE:MLM
NYSE:MLMBasic Materials

Is It Too Late To Consider Martin Marietta Materials (MLM) After Its Strong Multi‑Year Rally?

If you are wondering whether Martin Marietta Materials shares still offer value after a strong run, this article will walk through what the current price might be implying about the company. The stock recently closed at US$678.46, with returns of 0.5% over 7 days, 4.5% over 30 days, 6.9% year to date, 41.5% over 1 year, 90.0% over 3 years and 111.9% over 5 years. This naturally raises questions about what is already priced in. Recent news coverage has focused on Martin Marietta Materials as...
NYSE:UGI
NYSE:UGIGas Utilities

UGI Infrastructure Upgrades And Pennsylvania Rate Case Shape Investor Outlook

UGI Utilities, a subsidiary of NYSE:UGI, has begun major infrastructure upgrades in Lancaster, Pennsylvania, focused on gas system safety and reliability. The Pennsylvania Public Utility Commission has opened a formal investigation into UGI Utilities' proposed natural gas rate changes affecting nearly 690,000 customers statewide. These developments center on long term service quality, customer bills, and how UGI balances investment needs with regulatory oversight. UGI, through UGI...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Enterprise (AXON) Margin Compression Challenges Bullish Growth Narratives After FY 2025 Results

Axon Enterprise (AXON) closed out FY 2025 with Q4 revenue of US$796.7 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$2.8 billion and EPS of US$1.60 that sit against a net profit margin of 4.5% versus 18.1% a year earlier. The company has seen revenue move from US$575.1 million in Q4 2024 to US$796.7 million in Q4 2025, while quarterly basic EPS shifted from US$1.77 to US$0.03 over the same period, with a US$107.5 million one off gain influencing the trailing...
NYSE:CNS
NYSE:CNSCapital Markets

Is Cohen & Steers (CNS) Pricing In Too Much Optimism After Real Assets Focus News?

If you are wondering whether Cohen & Steers is attractively priced right now, this article walks through what the current share price may or may not be reflecting about its underlying value. The stock last closed at US$67.14, with returns of 0.4% over 7 days, 3.1% over 30 days, 5.6% year to date, 4.1% over 3 years and 22.0% over 5 years, alongside a 19.7% decline over the past year that some investors may see as a reset in expectations. Recent news coverage has focused on Cohen & Steers as a...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Safety Insurance Group (SAFT) Sub 100% Combined Ratios Challenge Long Term Earnings Decline Narrative

Safety Insurance Group (SAFT) has wrapped up FY 2025 with Q4 revenue of US$319.3 million and basic EPS of US$1.37, rounding out a year in which trailing twelve month revenue reached about US$1.26 billion and EPS came in at US$6.75. Over recent quarters, the company has seen revenue move from US$286.7 million and EPS of US$0.55 in Q4 2024 to the latest Q4 2025 levels. The trailing net profit margin of 7.9% sits above the 6.3% recorded a year earlier, setting up a results season where higher...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Earnings Growth And 18% Margin Test Slowing Growth Narrative

Salesforce FY 2026 earnings snapshot Salesforce (CRM) has just wrapped up FY 2026 with Q4 revenue of US$11.2b and basic EPS of US$2.08, setting the tone for a year where investors are watching how top line scale and per share profitability move together. The company has seen quarterly revenue move from US$9.8b in Q1 FY 2026 to US$11.2b in Q4, with basic EPS ranging from US$1.61 to US$2.20 over the same stretch. Trailing 12 month revenue reached US$41.5b and EPS came in at US$7.85. Taken...
NasdaqGS:HURN
NasdaqGS:HURNProfessional Services

Is Huron Consulting Group (HURN) Attractively Priced After Recent Share Pullback?

If you are wondering whether Huron Consulting Group shares are attractively priced or asking too much, you are in the right place for a clear look at value. The stock most recently closed at US$143.29, with returns of 9.4% over 7 days, a 15.7% decline over 30 days, a 16.2% decline year to date, and a 4.2% decline over 1 year, set against a 73.0% return over 3 years and 174.7% over 5 years. Recent news around Huron has focused on its role as a consulting partner helping organizations handle...
NasdaqGM:LRMR
NasdaqGM:LRMRBiotechs

Larimar Therapeutics (LRMR) Is Up 85.9% After Breakthrough Status For Nomlabofusp In Friedreich’s Ataxia

In February 2026, Larimar Therapeutics announced that the FDA granted Breakthrough Therapy Designation to nomlabofusp for treating adults and children with Friedreich’s ataxia, while the company advanced plans for an accelerated Biologics License Application supported by skin frataxin as a novel surrogate endpoint. This combination of expedited regulatory status and FDA alignment on using a new biomarker underscores how central nomlabofusp has become to Larimar’s clinical and regulatory...
OTCPK:VXRT
OTCPK:VXRTBiotechs

Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention

Vaxart (VXRT) is drawing fresh attention ahead of its scheduled presentation at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026. Investors will be listening for pipeline and funding updates. See our latest analysis for Vaxart. Vaxart’s recent 34.83% 7 day share price return and 102.97% 90 day share price return point to building momentum ahead of the conference, even as the 5 year total shareholder return of 87.31% highlights longer term challenges. If...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Margin Compression To 6.9% Tests Bullish Profitability Narratives

MercadoLibre FY 2025 earnings snapshot MercadoLibre (MELI) has wrapped up FY 2025 with fourth quarter revenue of US$8.8b and basic EPS of US$11.03, alongside net income of US$559m, putting fresh numbers behind the recent share price of US$1,740.88. The company has seen quarterly revenue move from US$6.1b and EPS of US$12.60 in Q4 2024 to US$8.8b and EPS of US$11.03 in Q4 2025, while trailing twelve month EPS sits at US$39.39 on revenue of US$28.9b. This gives investors a basis to weigh high...
NasdaqGS:PICS
NasdaqGS:PICSDiversified Financial

PicS IPO Opens Brazilian Listings Return And Early Trading Test

PicS N.V. completed a US$434.3 million initial public offering. The company began trading on the Nasdaq Global Select Market under the ticker NasdaqGS:PICS. This is the first new stock listing by a Brazilian company in over four years. With its IPO now complete, PicS enters the public markets at a share price of $17.76 and a recent 7 day return of 17.6%. The listing of NasdaqGS:PICS also marks a return of Brazilian issuers to international equity markets after a multi year pause in new...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

Assessing International General Insurance Holdings (IGIC) Valuation After Extraordinary Cash Dividend Announcement

International General Insurance Holdings (IGIC) has put income front and center by declaring an extraordinary cash dividend of $1.15 per share, payable on April 6, 2026, to shareholders of record on March 18. See our latest analysis for International General Insurance Holdings. The extraordinary and ordinary dividends, along with the recently completed US$8.09 million buyback, come after a period where the share price has moved steadily rather than sharply. The 30 day share price return is...
NasdaqGS:TERN
NasdaqGS:TERNPharmaceuticals

Terns Pharmaceuticals (TERN) Valuation Check After Strong Recent Share Price Run And CML Narrative Shift

Terns Pharmaceuticals (TERN) has drawn attention after recent trading, with the stock closing at US$40.92. For investors, the clinical stage focus on oncology and obesity raises questions about how current pricing reflects trial progress and cash needs. See our latest analysis for Terns Pharmaceuticals. While the share price slipped around 1% on the day to US$40.92, it remains on a strong short term run, with a 16.61% 1 month share price return and a 45.57% 3 month share price return,...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

LifeStance Health Group (LFST) Profit Turn Challenges Skeptical Earnings Narratives

LifeStance Health Group (LFST) capped FY 2025 with fourth quarter revenue of US$382.2 million and basic EPS of US$0.03, while trailing twelve month revenue reached about US$1.4 billion with basic EPS of US$0.03. The company has seen revenue move from US$325.5 million in Q4 FY 2024 to US$382.2 million in Q4 FY 2025, alongside a shift in quarterly basic EPS from a loss of US$0.02 to a profit of US$0.03. This places improving profitability metrics at the center of the current earnings...